vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and MODIV INDUSTRIAL, INC. (MDV). Click either name above to swap in a different company.
Apyx Medical Corp is the larger business by last-quarter revenue ($19.2M vs $11.1M, roughly 1.7× MODIV INDUSTRIAL, INC.). MODIV INDUSTRIAL, INC. runs the higher net margin — 11.0% vs -6.8%, a 17.7% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs -5.6%). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs -3.8%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
MODIV INDUSTRIAL, INC. is a U.S.-based industrial real estate enterprise focused on acquiring, owning and operating high-quality industrial properties mainly located in key logistics and distribution hubs across North America. It serves tenants from sectors including e-commerce fulfillment, manufacturing and third-party logistics, addressing rising demand for modern supply chain infrastructure.
APYX vs MDV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $11.1M |
| Net Profit | $-1.3M | $1.2M |
| Gross Margin | 62.6% | — |
| Operating Margin | 0.1% | 45.8% |
| Net Margin | -6.8% | 11.0% |
| Revenue YoY | 34.7% | -5.6% |
| Net Profit YoY | 71.9% | -22.0% |
| EPS (diluted) | — | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $11.1M | ||
| Q3 25 | $12.9M | $11.7M | ||
| Q2 25 | $11.4M | $11.8M | ||
| Q1 25 | $9.4M | $11.8M | ||
| Q4 24 | $14.2M | $11.7M | ||
| Q3 24 | $11.5M | $11.7M | ||
| Q2 24 | $12.1M | $11.4M | ||
| Q1 24 | $10.2M | $12.0M |
| Q4 25 | $-1.3M | $1.2M | ||
| Q3 25 | $-2.0M | $1.0M | ||
| Q2 25 | $-3.8M | $-2.0M | ||
| Q1 25 | $-4.2M | $829.0K | ||
| Q4 24 | $-4.6M | $1.6M | ||
| Q3 24 | $-4.7M | $-587.0K | ||
| Q2 24 | $-6.6M | $1.3M | ||
| Q1 24 | $-7.6M | $3.7M |
| Q4 25 | 62.6% | — | ||
| Q3 25 | 64.4% | — | ||
| Q2 25 | 62.3% | — | ||
| Q1 25 | 60.1% | — | ||
| Q4 24 | 63.0% | — | ||
| Q3 24 | 60.5% | — | ||
| Q2 24 | 61.7% | — | ||
| Q1 24 | 58.1% | — |
| Q4 25 | 0.1% | 45.8% | ||
| Q3 25 | -6.5% | 41.4% | ||
| Q2 25 | -22.6% | 9.8% | ||
| Q1 25 | -32.4% | 40.2% | ||
| Q4 24 | -21.4% | 45.4% | ||
| Q3 24 | -31.6% | 42.0% | ||
| Q2 24 | -45.7% | 44.6% | ||
| Q1 24 | -64.6% | 55.6% |
| Q4 25 | -6.8% | 11.0% | ||
| Q3 25 | -15.4% | 9.0% | ||
| Q2 25 | -33.2% | -17.1% | ||
| Q1 25 | -44.0% | 7.0% | ||
| Q4 24 | -32.5% | 13.3% | ||
| Q3 24 | -40.9% | -5.0% | ||
| Q2 24 | -54.0% | 11.6% | ||
| Q1 24 | -74.0% | 31.1% |
| Q4 25 | — | $0.02 | ||
| Q3 25 | — | $0.00 | ||
| Q2 25 | — | $-0.32 | ||
| Q1 25 | — | $-0.01 | ||
| Q4 24 | — | $0.07 | ||
| Q3 24 | — | $-0.18 | ||
| Q2 24 | $-0.19 | $0.03 | ||
| Q1 24 | $-0.22 | $0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $14.4M |
| Total DebtLower is stronger | $37.5M | $261.5M |
| Stockholders' EquityBook value | $14.5M | $162.7M |
| Total Assets | $66.8M | $476.5M |
| Debt / EquityLower = less leverage | 2.58× | 1.61× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | $14.4M | ||
| Q3 25 | $25.1M | $8.3M | ||
| Q2 25 | $29.3M | $5.8M | ||
| Q1 25 | $31.0M | $6.2M | ||
| Q4 24 | $31.7M | $11.5M | ||
| Q3 24 | $28.0M | $6.8M | ||
| Q2 24 | $32.7M | $18.9M | ||
| Q1 24 | $37.3M | $18.4M |
| Q4 25 | $37.5M | $261.5M | ||
| Q3 25 | $37.5M | $279.7M | ||
| Q2 25 | $37.5M | $279.7M | ||
| Q1 25 | $37.5M | $279.7M | ||
| Q4 24 | $37.5M | $279.8M | ||
| Q3 24 | $37.5M | $279.7M | ||
| Q2 24 | — | $279.7M | ||
| Q1 24 | — | $279.6M |
| Q4 25 | $14.5M | $162.7M | ||
| Q3 25 | $5.8M | $164.8M | ||
| Q2 25 | $7.3M | $165.6M | ||
| Q1 25 | $10.5M | $171.1M | ||
| Q4 24 | $14.2M | $190.1M | ||
| Q3 24 | $11.0M | $186.3M | ||
| Q2 24 | $14.7M | $187.0M | ||
| Q1 24 | $20.3M | $188.0M |
| Q4 25 | $66.8M | $476.5M | ||
| Q3 25 | $57.4M | $499.6M | ||
| Q2 25 | $58.2M | $498.9M | ||
| Q1 25 | $60.2M | $506.8M | ||
| Q4 24 | $64.8M | $507.8M | ||
| Q3 24 | $60.7M | $507.4M | ||
| Q2 24 | $65.4M | $519.5M | ||
| Q1 24 | $70.7M | $522.5M |
| Q4 25 | 2.58× | 1.61× | ||
| Q3 25 | 6.41× | 1.70× | ||
| Q2 25 | 5.17× | 1.69× | ||
| Q1 25 | 3.57× | 1.63× | ||
| Q4 24 | 2.64× | 1.47× | ||
| Q3 24 | 3.40× | 1.50× | ||
| Q2 24 | — | 1.50× | ||
| Q1 24 | — | 1.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $15.0M |
| Free Cash FlowOCF − Capex | $-2.8M | — |
| FCF MarginFCF / Revenue | -14.6% | — |
| Capex IntensityCapex / Revenue | 1.4% | — |
| Cash ConversionOCF / Net Profit | — | 12.34× |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $15.0M | ||
| Q3 25 | $-3.5M | $4.1M | ||
| Q2 25 | $-1.2M | $3.9M | ||
| Q1 25 | $-702.0K | $3.0M | ||
| Q4 24 | $-2.9M | $18.2M | ||
| Q3 24 | $-4.4M | $5.1M | ||
| Q2 24 | $-4.3M | $4.7M | ||
| Q1 24 | $-6.3M | $3.0M |
| Q4 25 | $-2.8M | — | ||
| Q3 25 | $-4.1M | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-757.0K | — | ||
| Q4 24 | $-3.2M | — | ||
| Q3 24 | $-4.6M | — | ||
| Q2 24 | $-4.6M | — | ||
| Q1 24 | $-6.4M | — |
| Q4 25 | -14.6% | — | ||
| Q3 25 | -31.5% | — | ||
| Q2 25 | -13.2% | — | ||
| Q1 25 | -8.0% | — | ||
| Q4 24 | -22.4% | — | ||
| Q3 24 | -40.0% | — | ||
| Q2 24 | -38.0% | — | ||
| Q1 24 | -62.2% | — |
| Q4 25 | 1.4% | — | ||
| Q3 25 | 4.0% | — | ||
| Q2 25 | 2.3% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 1.7% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 2.4% | — | ||
| Q1 24 | 0.3% | — |
| Q4 25 | — | 12.34× | ||
| Q3 25 | — | 3.95× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.68× | ||
| Q4 24 | — | 11.72× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.55× | ||
| Q1 24 | — | 0.80× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
